Target intelligence / Profile preview

Plasmodium falciparum heme detoxification machinery

Molecular classification
Enzyme, Metabolic pathway, Other
01

Overview

The Plasmodium falciparum heme detoxification machinery is a critical metabolic pathway located within the parasite's acidic food vacuole (NIH, 2025). During the intra-erythrocytic stage, the parasite ingests and degrades host hemoglobin to obtain amino acids, a process that releases large quantities of toxic free heme (ferriprotoporphyrin IX) (NIH, 2021). To prevent heme-induced oxidative damage and membrane lysis, the parasite utilizes a specialized machinery—comprising proteins like Heme Detoxification Protein (HDP) and Histidine-Rich Proteins (HRPs), along with neutral lipids—to polymerize heme into an insoluble, chemically inert crystal known as hemozoin (PLOS Pathogens, 2008; NIH, 2021). This pathway is the primary target for several classes of antimalarial drugs, most notably the 4-aminoquinolines like chloroquine (NIH, 2013). These drugs interfere with the biocrystallization process by binding to heme or the crystal surface, leading to the accumulation of toxic heme-drug complexes that ultimately kill the parasite (ResearchGate, 2020; NIH, 2021).

Other names
Heme polymerization pathwayHemozoin formation machineryHeme detoxification protein complexHemozoin biocrystallization pathwayHeme detoxification pathwayHeme detoxification protein (HDP)
02

Mechanism of action

Inhibition of hemozoin formation through binding to heme monomers or the growing crystal surface, preventing the detoxification of ferriprotoporphyrin IX and leading to parasite death via oxidative stress and membrane damage (NIH, 2025; ResearchGate, 2025).

03

Biological functions

OtherCell death
04

Disease associations

Infection
05

Safety considerations

Drug resistance (e.g., PfCRT-mediated efflux)RetinopathyNeuropsychiatric toxicityCardiovascular toxicity (QT prolongation)
06

Interacting drugs

Chloroquine

8 more in the full profile.

07

Biomarkers

HemozoinFree heme (ferriprotoporphyrin IX)Histidine-rich protein 2 (HRP2)Parasite lactate dehydrogenase (pLDH)

Beyond the preview

Go deeper on Plasmodium falciparum heme detoxification machinery.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Plasmodium falciparum heme detoxification machinery.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call